Immunotherapy of cancer using interleukin 2: current status and future prospects
- PMID: 3076761
- DOI: 10.1016/0167-5699(88)91261-3
Immunotherapy of cancer using interleukin 2: current status and future prospects
Comment in
-
Immunotherapy of cancer using IL-2.Immunol Today. 1988 Jul-Aug;9(7-8):193-4. doi: 10.1016/0167-5699(88)91210-8. Immunol Today. 1988. PMID: 3267134 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
